MAWA
RMD icon

Moss Adams Wealth Advisors’s ResMed RMD Stock Holding History

Moss Adams Wealth Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$658K Buy
3,374
+225
+7% +$46.6K 0.04% 127
2026
Q1 		$707K Sell
3,149
-11
-0.3% -$2.74K 0.05% 112
2025
Q4 		$761K Buy
3,160
+20
+0.6% +$5.12K 0.06% 100
2025
Q3 		$860K Buy
3,140
+33
+1% +$9.01K 0.07% 87
2025
Q2 		$802K Buy
3,107
+28
+0.9% +$6.68K 0.07% 95
2025
Q1 		$689K Buy
3,079
+23
+0.8% +$5.37K 0.07% 88
2024
Q4 		$699K Buy
3,056
+13
+0.4% +$3.13K 0.07% 81
2024
Q3 		$743K Buy
3,043
+60
+2% +$13.4K 0.08% 71
2024
Q2 		$571K Buy
2,983
+77
+3% +$15.6K 0.08% 76
2024
Q1 		$575K Buy
2,906
+176
+6% +$32.3K 0.09% 70
2023
Q4 		$470K Buy
2,730
+322
+13% +$49.5K 0.1% 57
2023
Q3 		$356K Sell
2,408
-279
-10% -$50.4K 0.12% 56
2023
Q2 		$587K Buy
2,687
+117
+5% +$26.1K 0.19% 41
2023
Q1 		$563K Sell
2,570
-230
-8% -$49.9K 0.19% 39
2022
Q4 		$583K Buy
+2,800
New +$615K 0.29% 51

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Moss Adams Wealth Advisors's RMD Position: Q2 2026 in Review

Moss Adams Wealth Advisors increased its ResMed (RMD) stake by 7.1% in Q2 2026, buying an estimated $46.6K and bringing the position to 3,374 shares worth $658K. The position accounts for 0.04% of the portfolio, ranked #127.

Moss Adams Wealth Advisors first reported a position in RMD in Q4 2022 and has held it in 15 quarters since. The position peaked at $860K in Q3 2025. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Moss Adams Wealth Advisors held 3,374 shares of ResMed worth $658K as of Q2 2026.
  • Moss Adams Wealth Advisors bought 225 ResMed shares in Q2 2026, an estimated $46.6K.
  • ResMed made up 0.04% of Moss Adams Wealth Advisors's portfolio in Q2 2026, its #127 holding.
  • Moss Adams Wealth Advisors first reported a position in ResMed in Q4 2022 and has held it in 15 quarters since.
  • Moss Adams Wealth Advisors's ResMed position peaked at $860K in Q3 2025.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Moss Adams Wealth Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.